标题
Inflammasomes and Pyroptosis as Therapeutic Targets for COVID-19
作者
关键词
-
出版物
JOURNAL OF IMMUNOLOGY
Volume 205, Issue 2, Pages 307-312
出版商
The American Association of Immunologists
发表日期
2020-06-04
DOI
10.4049/jimmunol.2000513
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dehydrocostus lactone inhibits NLRP3 inflammasome activation by blocking ASC oligomerization and prevents LPS-mediated inflammation in vivo
- (2020) Yuanyuan Chen et al. CELLULAR IMMUNOLOGY
- Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
- (2020) Ning Tang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
- (2020) Jasper Fuk-Woo Chan et al. Emerging Microbes & Infections
- NLRP3 Inflammasome—A Key Player in Antiviral Responses
- (2020) Chunyuan Zhao et al. Frontiers in Immunology
- Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses
- (2020) Furong Qi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Weak Induction of Interferon Expression by SARS-CoV-2 Supports Clinical Trials of Interferon Lambda to Treat Early COVID-19
- (2020) Thomas R O’Brien et al. CLINICAL INFECTIOUS DISEASES
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- COVID-19 and emerging viral infections: The case for interferon lambda
- (2020) Ludmila Prokunina-Olsson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
- (2020) David E. Gordon et al. NATURE
- FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation
- (2020) Jun Jacob Hu et al. NATURE IMMUNOLOGY
- Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection
- (2020) Xin Zou et al. Frontiers of Medicine
- Type 1 interferons as a potential treatment against COVID-19
- (2020) Erwan Sallard et al. ANTIVIRAL RESEARCH
- Complement Receptor C5aR1 Inhibition Reduces Pyroptosis in hDPP4-Transgenic Mice Infected with MERS-CoV
- (2019) Yuting Jiang et al. Viruses-Basel
- Dampened NLRP3-mediated inflammation in bats and implications for a special viral reservoir host
- (2019) Matae Ahn et al. Nature Microbiology
- Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome
- (2019) I-Yin Chen et al. Frontiers in Microbiology
- Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC
- (2019) Kam-Leung Siu et al. FASEB JOURNAL
- Inflammasome Activation Triggers Blood Clotting and Host Death through Pyroptosis
- (2019) Congqing Wu et al. IMMUNITY
- The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
- (2019) Nathan Kelley et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Caspase-1 initiates apoptosis in the absence of gasdermin D
- (2019) Kohsuke Tsuchiya et al. Nature Communications
- Regulatory Mechanisms of the NLRP3 Inflammasome, a Novel Immune-Inflammatory Marker in Cardiovascular Diseases
- (2019) Na An et al. Frontiers in Immunology
- Gasdermin D activity in inflammation and host defense
- (2019) Judy Lieberman et al. Science Immunology
- Pharmacological Inhibitors of the NLRP3 Inflammasome
- (2019) Ayesha Zahid et al. Frontiers in Immunology
- Tranilast directly targets NLRP3 to treat inflammasome‐driven diseases
- (2018) Yi Huang et al. EMBO Molecular Medicine
- A Pilot Study of Tranilast for Cardiomyopathy of Muscular Dystrophy
- (2018) Tsuyoshi Matsumura et al. INTERNAL MEDICINE
- Influenza A Virus Infection Triggers Pyroptosis and Apoptosis of Respiratory Epithelial Cells through the Type I Interferon Signaling Pathway in a Mutually Exclusive Manner
- (2018) SangJoon Lee et al. JOURNAL OF VIROLOGY
- Caspase-11-dependent pyroptosis of lung epithelial cells protects from melioidosis while caspase-1 mediates macrophage pyroptosis and production of IL-18
- (2018) Jinyong Wang et al. PLoS Pathogens
- Inflammaging: a new immune–metabolic viewpoint for age-related diseases
- (2018) Claudio Franceschi et al. Nature Reviews Endocrinology
- Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension
- (2018) Shalini M Krishnan et al. CARDIOVASCULAR RESEARCH
- Kawasaki disease: epidemiology and the lessons from it
- (2017) Yosikazu Nakamura International Journal of Rheumatic Diseases
- Aging impairs both primary and secondary RIG-I signaling for interferon induction in human monocytes
- (2017) Ryan D. Molony et al. Science Signaling
- Gasdermins: Effectors of Pyroptosis
- (2017) Stephen B. Kovacs et al. TRENDS IN CELL BIOLOGY
- Role of the inflammasome in chronic obstructive pulmonary disease (COPD)
- (2017) Chiara Colarusso et al. Oncotarget
- Aging impairs both primary and secondary RIG-I signaling for interferon induction in human monocytes
- (2017) Ryan D. Molony et al. Science Signaling
- Quercetin Inhibits Inflammasome Activation by Interfering with ASC Oligomerization and Prevents Interleukin-1 Mediated Mouse Vasculitis
- (2017) Talita P. Domiciano et al. Scientific Reports
- Beyond the inflammasome: regulatory NOD-like receptor modulation of the host immune response following virus exposure
- (2016) Sheryl Coutermarsh-Ott et al. JOURNAL OF GENERAL VIROLOGY
- Mx1 reveals innate pathways to antiviral resistance and lethal influenza disease
- (2016) P. S. Pillai et al. SCIENCE
- Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer’s disease in rodent models
- (2016) Michael J. D. Daniels et al. Nature Communications
- TLR4-Upregulated IL-1β and IL-1RI Promote Alveolar Macrophage Pyroptosis and Lung Inflammation through an Autocrine Mechanism
- (2016) Xingying He et al. Scientific Reports
- RNase L Activates the NLRP3 Inflammasome during Viral Infections
- (2015) Arindam Chakrabarti et al. Cell Host & Microbe
- Silymarin Inhibits Morphological Changes in LPS-Stimulated Macrophages by Blocking NF-κB Pathway
- (2015) Eun Jeong Kim et al. KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
- Kawasaki disease: insights into pathogenesis and approaches to treatment
- (2015) Stanford T. Shulman et al. Nature Reviews Rheumatology
- Tranilast: A review of its therapeutic applications
- (2015) Sara Darakhshan et al. PHARMACOLOGICAL RESEARCH
- Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome
- (2015) Jose L. Nieto-Torres et al. VIROLOGY
- RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway
- (2014) Xiaqiong Wang et al. NATURE IMMUNOLOGY
- High dose anakinra for treatment of severe neonatal Kawasaki disease: a case report
- (2014) Ashley Shafferman et al. Pediatric Rheumatology
- Global gene expression profiling identifies new therapeutic targets in acute Kawasaki disease
- (2014) Long Truong Hoang et al. Genome Medicine
- Activation of NLRP3 Inflammasome in Alveolar Macrophages Contributes to Mechanical Stretch-Induced Lung Inflammation and Injury
- (2013) J. Wu et al. JOURNAL OF IMMUNOLOGY
- Inhibition of NF- B-Mediated Inflammation in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice Increases Survival
- (2013) M. L. DeDiego et al. JOURNAL OF VIROLOGY
- Type I IFN Triggers RIG-I/TLR3/NLRP3-dependent Inflammasome Activation in Influenza A Virus Infected Cells
- (2013) Julien Pothlichet et al. PLoS Pathogens
- A Virological View of Innate Immune Recognition
- (2012) Akiko Iwasaki Annual Review of Microbiology
- Interleukin-1β Is Crucial for the Induction of Coronary Artery Inflammation in a Mouse Model of Kawasaki Disease
- (2012) Youngho Lee et al. CIRCULATION
- Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
- (2012) Hye-Mi Lee et al. DIABETES
- Influenza enhances caspase-1 in bronchial epithelial cells from asthmatic volunteers and is associated with pathogenesis
- (2012) Rebecca N. Bauer et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Rapid induction of inflammatory lipid mediators by the inflammasome in vivo
- (2012) Jakob von Moltke et al. NATURE
- Critical role for calcium mobilization in activation of the NLRP3 inflammasome
- (2012) T. Murakami et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
- (2011) Greta Guarda et al. IMMUNITY
- Mitogen-Activated Protein Kinase Kinase 6 Mediates Mechanical Stretch-Induced High-Mobility Group Box 1 Protein Expression in Pulmonary Alveolar Epithelial Cells
- (2011) Ning Ding et al. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE
- Anti-inflammatory Compounds Parthenolide and Bay 11-7082 Are Direct Inhibitors of the Inflammasome
- (2010) Christine Juliana et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The NLRP3 Inflammasome Mediates In Vivo Innate Immunity to Influenza A Virus through Recognition of Viral RNA
- (2009) Irving C. Allen et al. IMMUNITY
- The Intracellular Sensor NLRP3 Mediates Key Innate and Healing Responses to Influenza A Virus via the Regulation of Caspase-1
- (2009) Paul G. Thomas et al. IMMUNITY
- Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1β production
- (2009) Hendrik Poeck et al. NATURE IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More